Details
Riboxin Indications
-Cardiac ischemia
- Cardiac arrhythmias, including cardiac glycosides obuslovlennyeprimeneniem
- Cardiomyopathy of various origins
- Congenital and acquired heart defects
- Myocarditis
- Coronary atherosclerosis
- "Pulmonary" heart
- Degenerative changes of the myocardium after severe physical work and infectious diseases
- Liver cirrhosis, acute and chronic hepatitis, alcoholic midicamental liver damage, fatty liver
- Operation on the isolated kidney.
Dosage & Administration
Riboxinum-Darnitsa (intraveneous injection solution 2%) .
Intravenously administered slowly (40-60 drops to 1 minute) infusion or bolus. First administered 200 mg (10 ml of a 2% solution) 1 time per day in terms vposleduyuschie good tolerability - 400 mg (20 ml of a 2% solution) 1-2 times a day. The course of treatment - 10-15 days.
Stream introduction of possible acute disorders ritmaserdtsa a single dose of 200-400 mg (10-20 ml of 2% solution).
For pharmacological protection kidneys undergoing ischemia is administered intravenously in razovoydoze 1.2 g (60 ml of a 2% solution) for 5-15 minutes before the renal artery clamping, AZAT another 0.8 g (40 ml of a 2% solution) immediately after restore circulation.
With a drip into a vein 2% solution of the drug razvodyatv 5% glucose solution or isotonic sodium chloride solution (250 ml).
Side effects
- Allergic reactions: itching, skin hyperemia
- Increase in the concentration of uric acid in the blood
- Exacerbation of gout chronic administration of high doses.
Contraindications
- hypersensitivity to the drug
- gout
- hyperuricemia
- pregnancy and lactation
- children up to age 18 years.
